Antitumoral activity of new pyrimidine derivatives of sesquiterpene lactones

Citation
A. Quintero et al., Antitumoral activity of new pyrimidine derivatives of sesquiterpene lactones, J PHARM P S, 2(3), 1999, pp. 108-112
Citations number
12
Categorie Soggetti
Pharmacology
Journal title
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES
ISSN journal
14821826 → ACNP
Volume
2
Issue
3
Year of publication
1999
Pages
108 - 112
Database
ISI
SICI code
1482-1826(199909/12)2:3<108:AAONPD>2.0.ZU;2-7
Abstract
Sesquiterpene lactones display a wide variety of biological effects such as antiviral, antiinflammatory and cytotoxic activity. In previous studies so me derivatives of sesquiterpene lactones were prepared to be tested as anti viral and/or cytoxic agents. In the present report we describe the effects of seven modified sesquiterpene lactones on the proliferation of several ca ncer cell lines. We demonstrated antitumoral activity of two of them: III ( JLNZ-106) and IV (EDAG-IV-Sme) in HeLa, C-33, CALO, INBL, VIPA, SW480, SW62 0, MCF-7 and CHO cancer cell lines. Compounds III (JLNZ-106) and IV (EDAG-I V-Sme-IV) presented cytotoxic activity (IC50) by inhibiting the incorporati on of C-14-thymidine to DNA. These experiments suggest that derivatives III and IV should inhibit DNA replication in cancer cell lines.